How many doses of Mounjaro (tirzepatide) are in a standard prefilled pen for a patient with type 2 diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mounjaro Pen Dosing Information

Each Mounjaro (tirzepatide) pen contains a single dose of medication. The pen is designed as a single-use, prefilled injection device that delivers one complete dose per pen 1.

Pen Specifications

  • Mounjaro comes in single-dose prefilled pens, with each pen containing one weekly dose of tirzepatide 2
  • The medication is also available in single-dose vials as an alternative formulation 2
  • Each pen is used once weekly for subcutaneous injection 1, 2

Available Dose Strengths

  • Tirzepatide is available in multiple dose strengths: 2.5 mg, 5 mg, 10 mg, and 15 mg per pen 1
  • The medication is initiated at 2.5 mg per week and escalated by 2.5 mg every 4 weeks until the assigned maintenance dose is achieved 3
  • The maximum approved dose is 15 mg weekly 1

Clinical Context

  • Tirzepatide is administered once weekly as a subcutaneous injection for type 2 diabetes management 4, 3
  • Unlike insulin pens that contain multiple doses (such as insulin pens with 3.0 mL cartridges allowing multiple injections), Mounjaro pens are single-use devices 5
  • Each pen should be discarded after the single injection is administered 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.